Introduction
Lung cancer is the leading cause of cancer-related mortality worldwide, with almost 1. Cancer Society). Cigarette smoking is estimated to cause 85-90% of lung cancers in the US (1, 2) . Although the prevalence of cigarette smoking in the US has declined, the age-adjusted mortality of lung cancer has not shown a comparable decrease, partly due to the increased risk of lung cancer in former smokers.
Cigarette smoke contains high concentrations of oxidants. These oxidants form highly reactive and potent reactive oxygen species (ROS) and can also stimulate alveolar macrophages to generate additional ROS and to release a host of mediators, some of which attract neutrophils and other inflammatory cells into the lung. Increased ROS production has been directly linked to oxidation of proteins, DNA, and lipids which can cause significant genetic and cellular damage. Oxidative damage plays a role in lung carcinogenesis and in the development of chronic obstructive pulmonary disease (COPD) (3, 4) .
Epidemiologic evidence suggests that there are gender differences in lung cancer pathogenesis and possible increased susceptibility to lung cancer in women (5) (6) (7) (8) while some studies suggested that women are not more susceptible than men to the carcinogenic effects of cigarette smoking in the lung (9, 10) . Several studies suggested that women may be more susceptible to oxidative DNA damage induced by cigarette smoking (11) (12) (13) (14) , but the role of smoking status and antioxidant capacity in differential susceptibility to oxidative damage has not been clearly established. Using baseline specimens (blood and urine) collected from current 4 and former heavy smokers enrolled in a chemopreventive trial, we evaluated the gender difference in oxidative damage and antioxidant capacity. 
Materials and Methods

Study Population
We recruited current smokers (CS) and former smokers (FS) between 40 and 80 years of age with ≥ 25 pack-years of smoking history to a randomized, double-blind, placebo controlled chemoprevention trial of green tea and black tea. Other eligibility criteria include normal liver and kidney function, no diagnosis of invasive cancer within the last 5 years, good performance status, not pregnant, not taking mega-doses of vitamins, no unstable cardiac disease, not having uncontrolled hypertension or uncontrolled diabetes, not immunosuppressed, no acute emphysema exacerbation within the past 6 month period, not requiring oxygen supplementation, and other criteria related tea and caffeine consumption. The study was approved by the University of Arizona Institutional Review Board.
Study Procedures
Once informed consent has been obtained, participants underwent eligibility evaluation for the intervention study. Each participant completed an Arizona Smoking Assessment Questionnaire, Arizona Food Frequency Questionnaire, Arizona Tea Questionnaire, and Health Assessment Questionnaire and was evaluated for health and respiratory history. A blood sample was collected for complete blood count (CBC) with differential and comprehensive metabolic panel.
Spirometry was performed to assess forced expiratory volume in 1 second (FEV 1 ) and forced vital capacity (FVC) using Nellcor® Puritan Bennett Renaissance PB100 spirometer.
Those who met all eligibility criteria underwent a 4-week placebo (8 placebo tea bags/48 oz water) run-in period. Participants who consumed at least 80% of the placebo tea bags underwent the baseline evaluation and were randomized to one of the intervention groups.
During the baseline evaluation, spirometry was repeated to assess the lung function. A fasting morning blood sample was collected and serum, buffy coat, and erythrocyte isolated and stored at -80°C prior to the sample analysis. First morning urine was collected on three consecutive mornings including the morning of the baseline visit. The three urine samples were combined in equal parts and aliquots stored at -80°C prior to the sample analysis. These baseline specimens were used to evaluate the gender difference in oxidative damage and antioxidant capacity in the current analysis and served as comparators with serial measures collected during and at the end of the study intervention (data to be reported in future publications).
Analysis of Urinary 8-Hydroxy-2'-deoxyguanosine (8OHdG)
Urinary 8OHdG was analyzed using a published HPLC-tandem mass spectrometry method (15) with minor modifications. The analysis was performed on a ThermoFinnigan TSQ Quantum triple quadrupole mass spectrometric system in tandem with a Surveyor LC system. The urine sample (50 μl) was diluted 1:1 with water and injected onto the HPLC system. HPLC separation was achieved with a BDS Hypersil C 18 column (150 x 2.1 mm, 5μ) and a gradient mobile phase of methanol and 10 mM ammonium formate at a flow rate of 0.2 ml/min. 8OHdG (from precursor ion m/z 284 to product ion m/z 168) was detected with multiple reaction monitoring (MRM) in the positive ion mode utilizing electrospray ionization. Linear calibration curves were established from 0.3 to 30 ng/mL. Urinary 8OHdG levels were normalized by urinary creatinine concentrations. Urine creatinine concentrations were determined using a creatinine test kit from Diazyme Laboratories.
Analysis of Urinary 8-Isoprostaglandin F 2α (8-iso-PGF 2α )
Urinary 8-iso-PGF 2α was analyzed using a published HPLC-tandem mass spectrometry method (16) with minor modifications. The analysis was performed on a ThermoFinnigan TSQ Quantum triple quadrupole mass spectrometric system in tandem with a Surveyor LC system. The urine sample (1 ml) was extracted with a solid phase extraction procedure before injecting onto the HPLC system. HPLC separation was achieved with a BDS Hypersil C 18 column (150 x 2.1 mm, 5μ) and an isocratic mobile phase consisting of 2 mM ammonium acetate, methanol, and acetonitrile at a flow rate of 0.2 ml/min. 8-iso-PGF 2α (from precursor ion m/z 353 to product ion m/z 193) and the isotope labeled internal standard, 8-iso-PGF 2α -D4 (from precursor ion m/z 357 to product ion m/z 197) were detected with multiple reaction monitoring (MRM) in the negative ion mode utilizing electrospray ionization. Linear calibration curves were established from 0.04 to 4 ng/mL. The urinary 8-iso-PGF 2α levels were normalized by urinary creatinine concentrations.
Determination of Antioxidant Enzymes in Erythrocytes
Glutathione peroxidase (GPx) activity in diluted erythrocyte lysates was determined using a Cayman Chemical Glutathione Peroxidase Assay kit. The glutathione peroxidase activity was determined by a coupled reaction with glutathione reductase. Oxidized glutathione, produced upon reduction of hydroperoxide by glutathione peroxide, is recycled to its reduced state by glutathione reductase and NADPH. The oxidation of NADPH to NADP + is accompanied by a decrease in absorbance at 340 nm. Under conditions in which the glutathione peroxidase activity is rate limiting, the rate of decrease in the absorbance at 340 nm is directly proportional to the glutathione peroxidase activity in the sample.
Superoxide dismutase (SOD) activity in diluted erythrocyte lysates was determined using a Cayman Chemical Superoxide Dismutase Assay kit. The kit utilizes xanthine oxidase and hypoxanthine to generate superoxide radicals. A tetrazolium salt reacts with superoxide radicals to form a red formazan dye that can be detected at 450 nm. Superoxide dismutase inhibits the formation of the formazan dye, and the activity is measured as percent inhibition compared with a calibration curve with purified superoxide dismutase. One unit of superoxide dismutase is defined as the amount of enzyme that inhibits the rate of the formazan dye formation by 50%.
The erythrocyte antioxidant enzyme activity was normalized by hemoglobin concentrations.
Hemoglobin concentrations in diluted erythrocyte lysates were determined using a hemoglobin assay kit from Teco Diagnostics.
Determination of Serum Fat Soluble Antioxidant Vitamins
The serum levels of retinols, carotenoids and tocopherols were determined by HPLC. Serum 
AFFQ & Dietary micronutrients
As part of the study requirements, all subjects at baseline completed the Arizona Food Frequency Questionnaire (AFFQ) which consists of a semi-quantitative 159-item questionnaire as has been previously validated (17) . Respondents reported how often they usually consume each particular food over the prior 12-month period (as a number of times per day, week, or month) and whether the usual portion size was small, medium or large. Age-sex specific portion size assumptions are used in the subsequent nutrient calculations. Vitamin supplement use information is also collected in the AFFQ, and nutrient estimates, both including and excluding vitamin supplements, are estimated. AFFQ output includes the estimated specific nutrients per day including dietary carotenoids, retinol, vitamin A and vitamin E.
Statistical Analysis
Descriptive analyses were performed to compare baseline characteristics, systemic oxidative damage, and antioxidant levels by gender and smoking status of the study population.
Comparisons between males and females or between FS and CS were conducted using t tests for continuous variables and X2 tests for categorical variables. Means were adjusted for potential confounders, including age, BMI, pack-years, FEV1/FVC (%), and dietary micronutrients (retinol, total carotenoids, and α-tocopherol) intake. Pearson correlations were calculated to assess the unadjusted relationships between the biomarkers of oxidative damage and the antioxidant biomarkers. Because these analyses were performed to explore the potential gender difference, we did not adjust the p-value for multiple comparisons. P ≤ 0.05 was interpreted as statistically significant. All statistical analyses were performed using Stata Statistical Software (Stata 11; College Station, TX). 
Results
Between September, 2003 and December, 2007, we prescreened 1,800 individuals and consented 319 subjects for study participation. A total of 146 subjects, comprising 80 females and 66 males, provided specimens at baseline evaluation. These baseline specimens were used for cross-sectional analysis of the gender difference in oxidative damage and antioxidant capacity. Table 1 summarizes the overall characteristics of the subjects included in the crosssectional analysis. Forty-two percent of the subjects were former smokers. There was no gender difference in the proportion of former smokers. The average age was 60.2 ± 8.8. There was no difference in age between female and male subjects. The average BMI was 28. Less than 6% of the subjects were taking multi-vitamin supplement, with no gender difference in the proportion of subjects taking multi-vitamin supplement. There was no gender difference in dietary antioxidant intake, although females showed a trend of higher dietary carotenoids intake (13328 ±10748 vs. 10797 ± 6528 µg/day, p = 0.101). Table 2 
vs. 344 ± 250 ng/mg creatinine, p = 0.008) than male subjects. The gender difference in oxidative DNA and lipid biomarkers was only significant in CS (p = 0.050 for 8OHdG and p = 0.021 for 8-iso-PGF 2α ). The urinary 8OHdG levels were not statistically significant different between FS and CS in both females and males. The female FS had non-significantly lower levels of urinary 8-iso-PGF 2α than female CS (p = 0.059) while the the 8-iso-PGF 2α levels were similar between male FS and CS (p = 0.357).
Erythrocyte GPx levels did not differ by gender nor by smoking status, although female CS showed a trend for lower GPx levels than the other subgroups (p=0.053 vs. female FS; p=0.179 vs. male CS). There was no overall difference in erythrocyte SOD levels by gender. However, female CS had significantly lower levels of erythrocyte SOD than male CS (p = 0.019).
Erythrocyte SOD levels in female CS were also significantly lower than female FS (p = 0.002).
Serum levels of retinols, carotenoids and tocopherols were determined to assess the levels of fat soluble antioxidants. Female subjects had significantly higher serum β-carotene levels than males (p<0.001) and the gender difference was significant for both FS (p=0.023) and CS (p=0.001). Female CS also had higher levels of β-cryptoxanthin (p=0.015) and α-tocopherol (p=0.042) than male CS. Differences in fat soluble antioxidants among FS and CS were noted among male subjects; male CS had a trend for lower levels or significantly lower levels of a number of fat soluble antioxidants than FS (p=0.091 for retinol; p=0.112 for β-carotene; p=0.005 for β-cryptoxanthin; p=0.003 for lutein/zeaxanthin). with serum β-carotene levels in both females (p=0.018) and males (p=0.041). Urinary 8-iso-PGF 2α levels were also inversely correlated with serum lycopene levels in females (p=0.041) but with retinol levels in males (p=0.013). 
Discussion
Our data indicate that female CS had significantly greater levels of oxidative DNA and lipid damage, as assessed by urinary 8OHdG and 8-iso-PGF 2α , respectively, than male CS despite female smokers having fewer pack years of smoking history and better lung function. The oxidative DNA damage in female FS was similar to that in female CS, although there was a large variation in the levels of oxidative DNA damage in female FS. The oxidative lipid damage in female FS was less than that in female CS, indicating a potential reversal of oxidative lipid damage after smoking cessation. In contrast, for males, there was no difference in the oxidative DNA or lipid damage in CS compared to FS. Consistent with our findings, Mooney and colleagues (11) showed in 140 heavy smokers that a marker of oxidative DNA damage, anti-5'-hydroxymethyl-2'-deoxyuridine autoantibody, was 50% higher in female smokers than in male smokers after adjusting for cigarettes smoked per day.
Our study used urinary 8OHdG as a marker of oxidative DNA damage. Among various oxidative DNA damage products, 8OHdG has been the most studied. 8OHdG is an oxidative adduct form of deoxyguanosine (18) . Urinary 8OHdG level has been validated as a biomarker of the extent of oxidative DNA modification (19) (20) (21) . Furthermore, the oxidation of guanine bases in replicating DNA leads to GC to TA transversion mutations (22) . The GC to TA transversions are found in the activated K-ras oncogene (23) and in the p53 tumor suppressor gene (24) tissue than male smokers (12) (13) (14) . Therefore, the higher levels of systemic oxidative damage, as assessed by urinary 8OHdG, observed in female smokers may reflect a higher level of DNA damage and mutation in the lung tissue.
The oxidation of cellular lipids, typically referred to as lipid peroxidation, is a central feature of oxidative stress. Our study used urinary 8-iso-PGF 2α as a biomarker for oxidative lipid damage.
8-iso-PGF 2α is one of a large number of prostanes produced during peroxidation of membrane lipids by free radicals and reactive oxygen species and then released into circulation and excreted in the urine (25) . Urinary measurement of 8-iso-PGF 2α has been shown to be a sensitive and specific indicator of lipid peroxidation in vivo (26) (27) (28) (29) . 8-iso-PGF 2α is biologically active and may play a role in pulmonary pathophysiology (30) . One recent study suggested that higher levels of urinary 8-iso-PGF 2α may be associated with increased lung cancer risk (31) . Consistent with our finding, previous studies have also shown that female smokers have higher urinary 8-iso-PGF 2α (32, 33) . However, there are several potential limitations in using this biomarker as a measure of oxidative stress. First,, recent studies suggested that urinary metabolites of 8-iso-PGF 2α may be a more sensitive marker of endogenous oxidative stress status than the parent compound 8-iso-PGF 2α (34) . Second, urinary 8-iso-PGF 2α measurements as an indicator of systemic oxidative stress can potentially be affected by local renal production (35) .
Previous studies have shown divergent gender effects on antioxidant enzymes, possibly due to inclusion of different study populations (36, 37) . Our study did not find gender differences in GPx, although there was a trend for lower GPx in female CS. We observed a significant 
contribute to the greater degree of oxidative damage in female CS. However, biomarkers of oxidative damage did not appear to correlate significantly with the antioxidant enzymes.
Our data also showed that serum β-carotene levels in female subjects were significantly higher than male subjects and the gender difference was significant for both FS and CS. Female CS also had higher levels of β-cryptoxanthin and α-tocopherol than male CS. Previous studies have demonstrated gender differences in plasma levels of fat soluble antioxidant vitamins (38) (39) (40) .
Our study suggests that the higher levels of fat soluble antioxidants in female CS did not protect them against oxidative DNA and lipid damage. Several large randomized clinical trials showed that β-carotene supplementation increased lung cancer incidence in cigarette smokers (41, 42) .
Beta-carotene can function as a pro-oxidant under certain conditions of oxygen tension and high solute concentration (43, 44) . It has been suggested that chemicals in cigarette smoke and the resultant inflammatory response in the lung enhance the prospect for the formation of unusual β-carotene oxidant and other reactive species (43, 44) which may lead to higher levels of oxidative stress. Nevertheless, our data showed that β-carotene levels in our study population were not correlated with 8OHdG levels and were inversely associated with 8-iso-PGF 2α levels.
Gender differences in xenobiotic metabolism could be a plausible mechanism responsible for the greater degree of oxidative stress we noted among female smokers. Female hormones, most notably estrogen, may regulate expression of cytochrome P450 (CYP) enzymes. In one study, female lungs had 2.4 times more CYP1A1 mRNA than did male lungs (12) . Since CYP1A1 converts chemicals in cigarette smoke to potent oxidants and oxidizers, increased expression of CYP1A1 would lead to higher levels of oxidative stress as demonstrated by a significant correlation between CYP1A1 expression and DNA adduct level (12) . In addition, women were found to have a DNA repair capacity that is 10-15% lower than that in men (45) which could also contribute to gender differences in oxidative stress.
In the current study population, all female subjects were posmenopausal with only two subjects on hormone replacement therapy. Most studies examining the relationship between menopausal status and oxidative stress have shown that postmenopausal women have increased oxidative stress and decreased antioxidant status compared to premenopausal women (46) (47) (48) (49) . Elevation of body iron status, decrease in estrogen level, and/or increase in trunk fat mass has been suggested to play a role in increased oxidative stress in postmenopausal women (46) (47) (48) (49) (50) . It is not known whether these factors would have contributed to the gender difference observed in our study.
Chronic smoking also causes airway and systemic inflammation. Previous studies have reported differential expression of pro-inflammatory cytokines between men and women (51-53).
Since oxidative stress can be the cause or consequence of inflammation, the contribution of gender difference in pro-inflammatory cytokines to gender difference in oxidative damage warrants further investigation.
In conclusion, our study showed that female CS have a greater extent of systemic oxidative DNA and lipid damage despite having higher serum levels of fat soluble antioxidant. There was a trend for lower erythrocyte antioxidant enzymes in female CS, which may contribute to the greater extent of oxidative damage. 
